Weekly Recap | Guardant Health -2.5%, most brokers rate it buyWeekly Review·2 days ago, 08:18 AMGH-1.04%
Weekly Recap | Vertex Pharma -5.62%, low-volume pullback lags the S&P 500Weekly Review·2 days ago, 07:06 AMVRTX+0.17%
Weekly Recap | Twist Bioscience +2%, consensus target below spotWeekly Review·2 days ago, 07:00 AMTWST+0.29%
Weekly Recap | 10X Genomics +9.48%, insider selling alongside the rallyWeekly Review·2 days ago, 06:56 AMTXG+3.33%
Weekly Recap | Natera +0.23%, consensus target above spotWeekly Review·2 days ago, 06:29 AMNTRA+0.86%
Weekly Recap | Moderna -1.09%, tumour vaccine milestoneWeekly Review·2 days ago, 06:22 AMMRNA+5.38%MRNY+4.71%
Weekly Recap | Illumina -5.39%, insider selling fuels valuation debateWeekly Review·2 days ago, 06:07 AMILMN+2.57%
Weekly Recap | Twist Bioscience -11.78%, giving back prior gainsWeekly Review·Sep 5 at 08:18 AMTWST+0.29%
Weekly Recap | Moderna +5.48%, consensus target below spotWeekly Review·Sep 5 at 07:36 AMMRNA+5.38%MRNY+4.71%
Weekly Recap | Guardant Health -0.06%, choppy week ends nearly flatWeekly Review·Sep 5 at 06:55 AMGH-1.04%
Weekly Recap | Twist Bioscience -2.89%, most brokers rate it buyWeekly Review·Aug 29 at 06:36 AMTWST+0.29%
